E-pharmacy unicorn PharmEasy has reportedly breached its loan covenant terms with Goldman Sachs after it failed to raise ₹1,000 crore, The Economic Times reported. PharmEasy hasn't defaulted on any of its payment obligations yet despite failing to raise the equity after trying for a year and delaying its IPO. PharmEasy had borrowed ₹2,280 crore from Goldman Sachs in August 2022.